JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Characterizing the Use of Time-Limited Trials in Patients With Acute Respiratory Failure: A Prospective, Single-Center Observational Study

  • 0Department of Medicine, Division of Allergy, Pulmonary, and Critical Care, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Critical Care Explorations +

|

September 16, 2024

|

September 16, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Time-limited trials (TLTs) were used in 20.5% of acute respiratory failure patients, primarily those near end of life. Physician variation in TLT use suggests a need for evidence-based guidelines to optimize critical care decisions.

Area Of Science

  • Critical Care Medicine
  • Pulmonology
  • Medical Ethics

Background

  • Time-limited trials (TLTs) offer a structured approach to managing uncertainty in critical illness by setting a defined period for life-sustaining therapy.
  • The current utilization and patterns of TLTs in patients with acute respiratory failure (ARF) remain largely uncharacterized.

Purpose Of The Study

  • To investigate and characterize the use of time-limited trials (TLTs) in adult patients experiencing acute respiratory failure (ARF).

Main Methods

  • A prospective, 12-month observational cohort study was conducted at a U.S. academic medical center.
  • Included were adult intensive care unit (ICU) patients with ARF requiring invasive mechanical ventilation for at least 48 hours.
  • Data on patient characteristics, care delivery, and outcomes were extracted from electronic medical records, with TLT participation identified by ICU physicians.

Main Results

  • Of 176 eligible patients, 36 (20.5%) participated in a TLT. Physician participation in TLTs varied significantly (0-39% of patients).
  • TLT patients were older, had higher comorbidity scores, and were more likely to die or be discharged to hospice (80.6%) compared to non-TLT patients.
  • TLT use was associated with a shorter ICU length of stay (median 5.7 days vs. 10.3 days).

Conclusions

  • Approximately one in five patients with ARF engaged in a TLT, predominantly those nearing end of life.
  • Significant variation exists among physicians in the application of TLTs.
  • There is a clear need for evidence-based guidelines to standardize and optimize the use of TLTs in critical care settings.

Related Concept Videos

Acute Respiratory Failure-V 01:29

124

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Acute Respiratory Failure-IV 01:23

131

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...

Acute Respiratory Failure-III 01:30

162

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...

Acute Respiratory Failure-II 01:21

183

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

• Ventilation-Perfusion (V/Q)...

Acute Respiratory Failure-I 01:21

178

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

Ventilatory Modes 01:14

90

Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...